Authors: Gillespie, AM Broadhead, TJ Chan, SY Owen, J Farnsworth, AP Sopwith, M Coleman, RE

Citation: Am. Gillespie et al., Phase I open study of the effects of ascending doses of the cytotoxic immunoconjugate CMB-401 (hCTMO1-calicheamicin) in patients with epithelial ovarian cancer, ANN ONCOL, 11(6), 2000, pp. 735-741